Nestle Health Science SA has inked a deal with US-based nutraceutical player ChromaDex Corp. to tap into the growing healthy aging market globally as it looks to increase its presence in consumer healthcare.
The two firms have signed a global commercial license and supply agreement for ingredient sales of ChromaDex’ Tru Niagen dietary supplement for certain Nestlé
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?